{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T04:09:09Z","timestamp":1781323749708,"version":"3.54.1"},"reference-count":26,"publisher":"Wiley","issue":"1-2","license":[{"start":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T00:00:00Z","timestamp":1240531200000},"content-version":"vor","delay-in-days":4861,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[1996,1,2]]},"abstract":"<jats:p><jats:bold>Abstract: <\/jats:bold> Acquired deficiency of antithrombin (AT), which in some patients could lead to thrombosis, has been a serious side effect of protocols which incorporate <jats:italic>E. coli<\/jats:italic> L\u2010asparaginase (ASP) for the treatment of acute lymphoblastic leukaemia (ALL). In a longitudinal, prospective, non\u2010randomized study children with ALL (<jats:italic>n<\/jats:italic> = 27) were treated according to the protocol ALL\u2010BFM\u201090. During the induction phase using prednisone, vincristine, daunorubicin and ASP, AT substitution was performed in 15\/27 patients, when their plasma concentration decreased below 60% of normal with a concomitant increase of D\u2010dimer formation. After the administration of the AT concentrate the patients, plasma concentration of AT increased and remained elevated after 18, 48 and 72 h. In addition, the plasma concentration of enhanced thrombin generation, D\u2010dimer formation and plasminogen activator inhibitor 1 decreased towards normal levels. Although the observed laboratory findings may serve as evidence for a possible clinical benefit of AT substitution during ASP treatment, further randomized studies are requested to evaluate whether the use of prophylactic AT administration could reduce the incidence of thromboembolic events in childhood acute leukaemia.<\/jats:p>","DOI":"10.1111\/j.1600-0609.1996.tb00290.x","type":"journal-article","created":{"date-parts":[[2010,7,18]],"date-time":"2010-07-18T05:38:12Z","timestamp":1279431492000},"page":"35-38","source":"Crossref","is-referenced-by-count":36,"title":["Inhibition of hypercoagulation by antithrombin substitution in <i>E. coli<\/i> L\u2010asparaginase\u2010treated children"],"prefix":"10.1111","volume":"56","author":[{"given":"U.","family":"Nowak\u2010G\u00f6ttl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Kun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. E. A.","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Boos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Kehrel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Rath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"J\u00fcrgens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,4,24]]},"reference":[{"key":"e_1_2_1_2_2","volume-title":"Cancer Medicine","author":"Capicci R.","year":"1992"},{"key":"e_1_2_1_3_2","first-page":"303","volume-title":"Pediatric Clinic of North America","author":"Poplack DG","year":"1988"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19850215)55:4<702::AID-CNCR2820550405>3.0.CO;2-N"},{"key":"e_1_2_1_5_2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1055\/s-0038-1651179","article-title":"Evidence of hypercoagulable state in patients with acute lymphoblastic leukemia treated with low dose of E. coli asparaginase. A GIMEMA study","volume":"69","author":"Leone G.","year":"1993","journal-title":"Thromb Haemostas"},{"key":"e_1_2_1_6_2","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1182\/blood.V83.2.386.386","article-title":"Increased endogenous thrombin generation in children with acute lymphoblastic leukemia: risk of thrombotic complications in L asparaginase\u2010induced antithrombin III deficiency","volume":"83","author":"Mitchell L.","year":"1994","journal-title":"Blood"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001721-199401000-00005"},{"key":"e_1_2_1_8_2","unstructured":"Nowak\u2010G\u00f6ttlU. BoosJ. WerberG. AhlkeE. J\u00fcrgensH.Dependence of asparaginase\u2010induced coagulopathy on serum asparaginase activity: A randomized trial. In:B\u00fcchnerT. HiddemannW. W\u00f6rmannB. RitterJ. eds.Haematology and Blood Transfusion. Acute Leukemias VI.1995: In press."},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0268-9499(94)90248-8"},{"issue":"2","key":"e_1_2_1_10_2","first-page":"120","article-title":"Effect of disease and chemotherapy on hemostasis in children with acute lymphoid leukemia","volume":"16","author":"Mitchell L.","year":"1994","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(75)90078-X"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(83)90407-3"},{"key":"e_1_2_1_13_2","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/clinchem\/30.6.860","article-title":"Automated amidolytic method for determinating heparin, a heparinoid, and low\u2010MR heparin fragment, based on their anti\u2010xa activity","volume":"30","author":"Cate H.","year":"1984","journal-title":"Clin Chem"},{"key":"e_1_2_1_14_2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1055\/s-0038-1647475","article-title":"Determination of human prothrombin activation fragment 1 + 2 in plasma with antibody against a synthetic peptide","volume":"65","author":"Pelzer H.","year":"1991","journal-title":"Thromb Haemostas"},{"key":"e_1_2_1_15_2","first-page":"588","article-title":"Assessment of D\u2010dimer assays for the diagnosis of deep vein thrombosis","volume":"110","author":"Heaton DC","year":"1987","journal-title":"J Lab Clin Med"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-662-05747-6"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(82)80536-2"},{"key":"e_1_2_1_18_2","first-page":"179","article-title":"Intravascular coagulation phenomena associated with prevalent fall in fibrinogen and plasminogen in leukemic children","author":"Legnani C.","year":"1988","journal-title":"Haemostasis"},{"key":"e_1_2_1_19_2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1055\/s-0038-1647150","article-title":"Unbalanced coagulation\u2010fibrinolysis potential during L\u2010asparaginase therapy in children with acute lymphoblastic leukemia","volume":"64","author":"Semeraro N.","year":"1990","journal-title":"Thromb Haemostas"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1025358"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI111777"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830360304"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.72.1.36"},{"key":"e_1_2_1_24_2","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1055\/s-0038-1646885","article-title":"Effect of heparin and\/or antithrombin III on the generation of endotoxin\u2010induced plasminogen activator inhibitor","volume":"62","author":"Gomez C.","year":"1989","journal-title":"Thromb Haemostas"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1990.tb06336.x"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001721-199402000-00004"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(93)90037-O"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.1996.tb00290.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0609.1996.tb00290.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T08:17:33Z","timestamp":1693383453000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.1996.tb00290.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,1,2]]},"references-count":26,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[1996,1,2]]}},"alternative-id":["10.1111\/j.1600-0609.1996.tb00290.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.1996.tb00290.x","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,1,2]]}}}